Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2023 Filed Feb 27, 2023 20:07 UTC |
Bramwell JamesEVP, Americas
|
GrantCommon Stock | 20,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000069 · wf-form4_167754639367246.xml · nonDerivative · entry 2 Bramwell James · CIK 0001776099 · EVP, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,821 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 20:08 UTC |
Couturier ChristopheEVP, AMEA
|
GrantStock Options (Right to Buy) · Derivative | 22,149 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000071 · wf-form4_167754646099132.xml · derivative · entry 5 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149 Underlying: Common Stock · 22,149 shares Expires 2033-02-24 F4 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 20:08 UTC |
Couturier ChristopheEVP, AMEA
|
GrantCommon Stock | 9,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000071 · wf-form4_167754646099132.xml · nonDerivative · entry 3 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,508 F3 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:09 UTC |
Szlosek Thomas AEVP & CFO
|
GrantStock Options (Right to Buy) · Derivative | 54,135 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000073 · wf-form4_167754655204998.xml · derivative · entry 6 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,135 Underlying: Common Stock · 54,135 shares Expires 2033-02-24 F4 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:09 UTC |
Szlosek Thomas AEVP & CFO
|
GrantCommon Stock | 22,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000073 · wf-form4_167754655204998.xml · nonDerivative · entry 2 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,893 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:10 UTC |
Brophy GerardEVP, Biopharma Production
|
GrantStock Options (Right to Buy) · Derivative | 49,215 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000075 · wf-form4_167754659342287.xml · derivative · entry 4 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,215 Underlying: Common Stock · 49,215 shares Expires 2033-02-24 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:10 UTC |
Brophy GerardEVP, Biopharma Production
|
GrantCommon Stock | 20,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000075 · wf-form4_167754659342287.xml · nonDerivative · entry 2 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,728 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:09 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
GrantStock Options (Right to Buy) · Derivative | 12,963 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000074 · wf-form4_167754657364941.xml · derivative · entry 4 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,963 Underlying: Common Stock · 12,963 shares Expires 2033-02-24 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:09 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
GrantCommon Stock | 5,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000074 · wf-form4_167754657364941.xml · nonDerivative · entry 2 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,238 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:07 UTC |
Henson MeghanEVP, Chief HR Officer
|
GrantStock Options (Right to Buy) · Derivative | 29,529 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000070 · wf-form4_167754643577872.xml · derivative · entry 4 Henson Meghan · CIK 0001839411 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,529 Underlying: Common Stock · 29,529 shares Expires 2033-02-24 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:07 UTC |
Henson MeghanEVP, Chief HR Officer
|
GrantCommon Stock | 12,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000070 · wf-form4_167754643577872.xml · nonDerivative · entry 2 Henson Meghan · CIK 0001839411 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,984 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:09 UTC |
Vanderhaegen FredericEVP, Americas and Europe
|
GrantStock Options (Right to Buy) · Derivative | 49,215 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000072 · wf-form4_167754650090877.xml · derivative · entry 4 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas and Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,215 Underlying: Common Stock · 49,215 shares Expires 2033-02-24 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:09 UTC |
Vanderhaegen FredericEVP, Americas and Europe
|
GrantCommon Stock | 20,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000072 · wf-form4_167754650090877.xml · nonDerivative · entry 2 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas and Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,244 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:06 UTC |
Miller JustinEVP & General Counsel
|
GrantStock Options (Right to Buy) · Derivative | 22,149 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000068 · wf-form4_167754635851581.xml · derivative · entry 4 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149 Underlying: Common Stock · 22,149 shares Expires 2033-02-24 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:06 UTC |
Miller JustinEVP & General Counsel
|
GrantCommon Stock | 9,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000068 · wf-form4_167754635851581.xml · nonDerivative · entry 2 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,345 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:05 UTC |
Lewis SheriEVP, Global Ops & Supply Chain
|
GrantStock Options (Right to Buy) · Derivative | 29,529 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000067 · wf-form4_167754633851906.xml · derivative · entry 4 Lewis Sheri · CIK 0001839410 · EVP, Global Ops & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,529 Underlying: Common Stock · 29,529 shares Expires 2033-02-24 F3 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:05 UTC |
Lewis SheriEVP, Global Ops & Supply Chain
|
GrantCommon Stock | 12,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000067 · wf-form4_167754633851906.xml · nonDerivative · entry 2 Lewis Sheri · CIK 0001839410 · EVP, Global Ops & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,588 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:05 UTC |
Stubblefield MichaelDirector · President & CEO
|
GrantStock Options (Right to Buy) · Derivative | 239,915 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000066 · wf-form4_167754631657436.xml · derivative · entry 6 Stubblefield Michael · CIK 0001776153 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,915 Underlying: Common Stock · 239,915 shares Expires 2033-02-24 F4 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:05 UTC |
Stubblefield MichaelDirector · President & CEO
|
GrantCommon Stock | 99,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000066 · wf-form4_167754631657436.xml · nonDerivative · entry 2 Stubblefield Michael · CIK 0001776153 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,286,822 F2 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:05 UTC |
Sahin KittyEVP, Strategy&Corp Development
|
GrantStock Options (Right to Buy) · Derivative | 29,529 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0001722482-23-000065 · wf-form4_167754629681010.xml · derivative · entry 2 Sahin Kitty · CIK 0001963717 · EVP, Strategy&Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,529 Underlying: Common Stock · 29,529 shares Expires 2033-02-24 F2 · derivative.exercise_date: Reflects a grant of stock options that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 01:05 UTC |
Sahin KittyEVP, Strategy&Corp Development
|
GrantCommon Stock | 12,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000065 · wf-form4_167754629681010.xml · nonDerivative · entry 1 Sahin Kitty · CIK 0001963717 · EVP, Strategy&Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,875 F1 · kind: Reflects a grant of restricted stock units that vest in four equal annual installments beginning on February 24, 2024. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:07 UTC |
Bramwell JamesEVP, Americas
|
Tax withholdingCommon Stock | 569 | $24.59 | $13,991.71 |
DisclosureSEC source: 0001722482-23-000069 · wf-form4_167754639367246.xml · nonDerivative · entry 1 Bramwell James · CIK 0001776099 · EVP, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,513 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:08 UTC |
Couturier ChristopheEVP, AMEA
|
SaleCommon Stock | 3,078 | $24.24 | $74,610.72 |
DisclosureSEC source: 0001722482-23-000071 · wf-form4_167754646099132.xml · nonDerivative · entry 2 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,370 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 20:08 UTC |
Couturier ChristopheEVP, AMEA
|
Tax withholdingCommon Stock | 416 | $24.59 | $10,229.44 |
DisclosureSEC source: 0001722482-23-000071 · wf-form4_167754646099132.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,448 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:09 UTC |
Szlosek Thomas AEVP & CFO
|
Tax withholdingCommon Stock | 2,082 | $24.59 | $51,196.38 |
DisclosureSEC source: 0001722482-23-000073 · wf-form4_167754655204998.xml · nonDerivative · entry 1 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,790 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:10 UTC |
Brophy GerardEVP, Biopharma Production
|
Tax withholdingCommon Stock | 1,893 | $24.59 | $46,548.87 |
DisclosureSEC source: 0001722482-23-000075 · wf-form4_167754659342287.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,420 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:09 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 421 | $24.59 | $10,352.39 |
DisclosureSEC source: 0001722482-23-000074 · wf-form4_167754657364941.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,891 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:07 UTC |
Henson MeghanEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 816 | $24.59 | $20,065.44 |
DisclosureSEC source: 0001722482-23-000070 · wf-form4_167754643577872.xml · nonDerivative · entry 1 Henson Meghan · CIK 0001839411 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,799 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:09 UTC |
Vanderhaegen FredericEVP, Americas and Europe
|
Tax withholdingCommon Stock | 213 | $24.59 | $5,237.67 |
DisclosureSEC source: 0001722482-23-000072 · wf-form4_167754650090877.xml · nonDerivative · entry 1 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas and Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,936 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:06 UTC |
Miller JustinEVP & General Counsel
|
Tax withholdingCommon Stock | 468 | $24.59 | $11,508.12 |
DisclosureSEC source: 0001722482-23-000068 · wf-form4_167754635851581.xml · nonDerivative · entry 1 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,207 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:05 UTC |
Lewis SheriEVP, Global Ops & Supply Chain
|
Tax withholdingCommon Stock | 970 | $24.59 | $23,852.30 |
DisclosureSEC source: 0001722482-23-000067 · wf-form4_167754633851906.xml · nonDerivative · entry 1 Lewis Sheri · CIK 0001839410 · EVP, Global Ops & Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,403 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 23, 2023 Filed Feb 28, 2023 01:05 UTC |
Stubblefield MichaelDirector · President & CEO
|
Tax withholdingCommon Stock | 7,422 | $24.59 | $182,506.98 |
DisclosureSEC source: 0001722482-23-000066 · wf-form4_167754631657436.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187,818 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 22, 2023 Filed Feb 22, 2023 17:01 UTC |
Couturier ChristopheEVP, AMEA
|
SaleCommon Stock | 19,160 | $24.12 | $462,139.20 |
DisclosureSEC source: 0001722482-23-000063 · wf-form4_167710322289058.xml · nonDerivative · entry 2 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,160 F2 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.07 to $24.22, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 16:58 UTC |
Bramwell JamesEVP, Americas
|
Tax withholdingCommon Stock | 1,066 | $24.54 | $26,159.64 |
DisclosureSEC source: 0001722482-23-000058 · wf-form4_167710307425879.xml · nonDerivative · entry 1 Bramwell James · CIK 0001776099 · EVP, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,082 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 17:01 UTC |
Couturier ChristopheEVP, AMEA
|
Tax withholdingCommon Stock | 1,167 | $24.54 | $28,638.18 |
DisclosureSEC source: 0001722482-23-000063 · wf-form4_167710322289058.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,024 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 22:01 UTC |
Szlosek Thomas AEVP & CFO
|
Tax withholdingCommon Stock | 4,253 | $24.54 | $104,368.62 |
DisclosureSEC source: 0001722482-23-000064 · wf-form4_167710326646003.xml · nonDerivative · entry 1 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,872 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 22:00 UTC |
Miller JustinEVP & General Counsel
|
Tax withholdingCommon Stock | 1,167 | $24.54 | $28,638.18 |
DisclosureSEC source: 0001722482-23-000062 · wf-form4_167710318676245.xml · nonDerivative · entry 1 Miller Justin · CIK 0001776122 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,675 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 21:59 UTC |
Vanderhaegen FredericEVP, Americas & Europe
|
Tax withholdingCommon Stock | 398 | $24.54 | $9,766.92 |
DisclosureSEC source: 0001722482-23-000060 · wf-form4_167710312241266.xml · nonDerivative · entry 1 Vanderhaegen Frederic · CIK 0001776162 · EVP, Americas & Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,149 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 21:59 UTC |
Eck Steven WSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 435 | $24.54 | $10,674.90 |
DisclosureSEC source: 0001722482-23-000061 · wf-form4_167710314884316.xml · nonDerivative · entry 1 Eck Steven W · CIK 0001748813 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,312 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 21:58 UTC |
Brophy GerardEVP, Biopharma Production
|
Tax withholdingCommon Stock | 3,072 | $24.54 | $75,386.88 |
DisclosureSEC source: 0001722482-23-000059 · wf-form4_167710309252848.xml · nonDerivative · entry 1 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,313 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 21:57 UTC |
Stubblefield MichaelDirector · President & CEO
|
Tax withholdingCommon Stock | 15,026 | $24.54 | $368,738.04 |
DisclosureSEC source: 0001722482-23-000057 · wf-form4_167710304193226.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,195,240 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 20, 2023 Filed Feb 22, 2023 21:57 UTC |
Wondrasch MichaelEVP & CIO
|
Tax withholdingCommon Stock | 1,356 | $24.54 | $33,276.24 |
DisclosureSEC source: 0001722482-23-000056 · wf-form4_167710301553919.xml · nonDerivative · entry 1 Wondrasch Michael · CIK 0001776065 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,072 F1 · kind: Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 01:25 UTC |
Brophy GerardEVP, Biopharma Production
|
SaleCommon Stock | 11,339 | $25.06 | $284,155.34 |
DisclosureSEC source: 0001722482-23-000023 · wf-form4_167538752663268.xml · nonDerivative · entry 3 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,385 F3 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.00 to $25.15, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:26 UTC |
Couturier ChristopheEVP, AMEA
|
Tax withholdingCommon Stock | 7,658 | $23.90 | $183,026.20 |
DisclosureSEC source: 0001722482-23-000025 · wf-form4_167538756529193.xml · nonDerivative · entry 2 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,191 F3 · kind: Reflects shares of Common Stock withheld to cover the Reporting Person's tax liability in connection with the vesting and settlement of the performance-based restricted stock units described herein. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 20:26 UTC |
Couturier ChristopheEVP, AMEA
|
GrantCommon Stock | 26,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000025 · wf-form4_167538756529193.xml · nonDerivative · entry 1 Couturier Christophe · CIK 0001684076 · EVP, AMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,849 F1 · kind: Reflects performance-based restricted stock units previously granted to the Reporting Person, the performance of which was certified on January 31, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: Includes 683 shares acquired under the Avantor Employee Stock Purchase Plan. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:25 UTC |
Szlosek Thomas AEVP & CFO
|
Tax withholdingCommon Stock | 24,187 | $23.90 | $578,069.30 |
DisclosureSEC source: 0001722482-23-000021 · wf-form4_167538748974631.xml · nonDerivative · entry 2 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,574 F3 · kind: Reflects shares of Common Stock withheld to cover the Reporting Person's tax liability in connection with the vesting and settlement of the performance-based restricted stock units described herein. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:25 UTC |
Szlosek Thomas AEVP & CFO
|
GrantCommon Stock | 53,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000021 · wf-form4_167538748974631.xml · nonDerivative · entry 1 Szlosek Thomas A · CIK 0001293167 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,761 F1 · kind: Reflects performance-based restricted stock units previously granted to the Reporting Person, the performance of which was certified on January 31, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: Reflects a transfer by the Reporting Person of 14,270 shares into a Revocable Living Trust of which the Reporting Person is the sole beneficiary and sole trustee. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:26 UTC |
Stubblefield MichaelDirector · CEO
|
Tax withholdingCommon Stock | 91,140 | $23.90 | $2,178,246.00 |
DisclosureSEC source: 0001722482-23-000024 · wf-form4_167538754699684.xml · nonDerivative · entry 2 Stubblefield Michael · CIK 0001776153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,210,266 F3 · kind: Reflects shares of Common Stock withheld to cover the Reporting Person's tax liability in connection with the vesting and settlement of the performance-based restricted stock units described herein. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:26 UTC |
Stubblefield MichaelDirector · CEO
|
GrantCommon Stock | 223,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-23-000024 · wf-form4_167538754699684.xml · nonDerivative · entry 1 Stubblefield Michael · CIK 0001776153 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301,406 F1 · kind: Reflects performance-based restricted stock units previously granted to the Reporting Person, the performance of which was certified on January 31, 2023. Each performance-based restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer. F2 · balance_after: Reflects a transfer by the Reporting Person of 111,917 shares into a grantor retained annuity trust on December 9, 2022. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:25 UTC |
Brophy GerardEVP, Biopharma Production
|
Tax withholdingCommon Stock | 15,221 | $23.90 | $363,781.90 |
DisclosureSEC source: 0001722482-23-000023 · wf-form4_167538752663268.xml · nonDerivative · entry 2 Brophy Gerard · CIK 0001776107 · EVP, Biopharma Production 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,724 F2 · kind: Reflects shares of Common Stock withheld to cover the Reporting Person's tax liability in connection with the vesting and settlement of the performance-based restricted stock units described herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.